Jazz PharmaceuticalsJAZZ -1.99%73 Days Inventory is 290.71 as of Mar. 2026, which is 8% above its 10-year median of 269.33. GuruFocus rates JAZZ with a GF Score™ of 73/100 and a GF Value™ of $150.76 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 638 Biotechnology companies, Jazz Pharmaceuticals ranks worse than 70.38% on this metric.
The historical rank and industry rank for Jazz Pharmaceuticals's Days Inventory or its related term are showing as below:
JAZZ'
s Days Inventory Range Over the Past 10 Years
Min: 92.65 Med: 269.33 Max: 603.29
Current: 319.98
During the past 13 years, Jazz Pharmaceuticals's highest Days Inventory was 603.29. The lowest was 92.65. And the median was 269.33.
JAZZ's Days Inventory is ranked worse than 70.38% of 638
companies
in the Biotechnology industry
Industry Median: 183.195
vs JAZZ: 319.98
Jazz Pharmaceuticals's Days Inventory
declined
from Mar. 2025 (424.50) to Mar. 2026 (290.71).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Jazz Pharmaceuticals's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.31.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Jazz Pharmaceuticals's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.40.
Jazz Pharmaceuticals (NAS:JAZZ) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Jazz Pharmaceuticals's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Jazz Pharmaceuticals's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Jazz Pharmaceuticals Days Inventory Related Terms
Jazz Pharmaceuticals Days Inventory Historical Data
* Premium members only.
The historical data trend for Jazz Pharmaceuticals's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JAZZ vs BBIO, EXEL, IONS: Days Inventory Comparison
For the Biotechnology subindustry, Jazz Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jazz Pharmaceuticals Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Jazz Pharmaceuticals's Days Inventory distribution charts can be found below:
* The bar in red indicates where Jazz Pharmaceuticals's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jazz Pharmaceuticals (JAZZ) has a Days Inventory of 290.71 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Jazz Pharmaceuticals and its competitors. This is near median its historical median of 269.33. Over the past decade, Jazz Pharmaceuticals' Days Inventory has ranged from 92.65 to 603.29. According to the industry distribution chart, Jazz Pharmaceuticals ranks #449 out of 638 companies in the Biotechnology industry, placing it in the top 70.4%.
Is Jazz Pharmaceuticals' Days Inventory too high?
Jazz Pharmaceuticals' current Days Inventory of 290.71 is near median its 10-year median of 269.33. Over the past 10 years, this metric has ranged from a low of 92.65 to a high of 603.29. The Biotechnology industry median Days Inventory is 183.20. Jazz Pharmaceuticals' value of 290.71 is 58.7% above this industry median. Based on the distribution chart, Jazz Pharmaceuticals ranks #449 out of 638 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Jazz Pharmaceuticals has a GF Score™ of 73/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Jazz Pharmaceuticals' Days Inventory compare to BBIO and EXEL?
According to the Biotechnology industry distribution chart, Jazz Pharmaceuticals ranks #449 out of 638 companies for Days Inventory. This places Jazz Pharmaceuticals in the lower half of its industry. The industry median Days Inventory is 183.20. Jazz Pharmaceuticals' value of 290.71 is 58.7% above this benchmark. Historically, Jazz Pharmaceuticals' own Days Inventory has ranged from 92.65 to 603.29 over the past decade. While the company's 10-year median is 269.33 vs. the industry median of 183.20, Jazz Pharmaceuticals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jazz Pharmaceuticals's current Days Inventory of 290.71 is 58.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Jazz Pharmaceuticals and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jazz Pharmaceuticals's current Days Inventory is 290.71, which is near median its own 10-year median of 269.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jazz Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Jazz Pharmaceuticals (JAZZ) is currently considered Significantly Overvalued. The stock's GF Value™ is $150.76, compared to a current price of $238.94 — trading 58.5% above its estimated fair value. The current Days Inventory is 290.71, which is near median its 10-year median of 269.33 and 58.7% above the Biotechnology industry median of 183.20. Jazz Pharmaceuticals' overall GF Score™ is 73/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Jazz Pharmaceuticals (JAZZ), the current Days Inventory is 290.71 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jazz Pharmaceuticals (JAZZ) Overvalued in 2026?
Based on GuruFocus' analysis, Jazz Pharmaceuticals stock appears to be overvalued.
The current stock price of $238.94 is trading 58.5% above its estimated GF Value™ of $150.76.
GuruFocus considers Jazz Pharmaceuticals to be Significantly Overvalued.
Key valuation signals for JAZZ:
Days Inventory: 290.71 (near median its 10-year median of 269.33)
GF Value™: $150.76 vs. price of $238.94 (58.5% above fair value)
Industry Position: 58.7% above the Biotechnology median (#449 of 638)
No single metric tells the full story. See the JAZZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
73GF Score
Get the complete analysis for JAZZ
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JAZZ has been successfully added to your 
